Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07816016) titled 'fREMS for Mortality Prediction in TBI' on Sept. 7.

Study Type: Observational

Primary Sponsor: Al-Nahrain University

Condition: TBI TBI Traumatic Brain Injury

Recruitment Status: Not recruiting

Date of First Enrollment: September 1, 2026

Target Sample Size: 2000

Countries of Recruitment: Iraq

To know more, visit https://clinicaltrials.gov/study/NCT07816016

Published by HT Digital Content Services with permission from Health Daily Digest....